Smith+Nephew expands margins and cash flow—What it means for shareholders
Smith+Nephew, a global leader in medical technology, has reported a strong financial performance for 2024, highlighting steady revenue growth, increased profitability, and record-breaking cash flow. ... Read More
Smith+Nephew redefines shoulder arthroplasty with stemless implant in AETOS Shoulder System
Smith+Nephew, a global leader in medical technology (LSE: SN, NYSE: SNN), has made a significant leap in orthopaedic surgical innovation with the introduction of the ... Read More
Smith+Nephew wraps up $330m acquisition of CartiHeal to expand sports medicine reach
Smith+Nephew, a global leader in medical technology, has officially completed the acquisition of CartiHeal, the developer of Agili-C, a novel sports medicine technology designed for ... Read More
Smith+Nephew announces $330m acquisition of CartiHeal for innovative cartilage regeneration technology
Smith+Nephew, a global medical technology leader, today announced its definitive agreement to acquire CartiHeal, the developer of Agili-C, a novel sports medicine technology. The acquisition, ... Read More